EDGAR Filing Documents for 0001193125-15-184263

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0001193125-15-184263

Filing Date

2015-05-13

Accepted

2015-05-12 17:42:35

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	d923749dsc13d.htm	SC 13D	66546
2	EX-99.B	d923749dex99b.htm	EX-99.B	19750
	Complete submission text file	0001193125-15-184263.txt		87800

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803

Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 781-365-2596

CoLucid Pharmaceuticals, Inc. (Subject) CIK: 0001348649 (see all company filings)

IRS No.: 203419541 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88836 | Film No.: 15855689
SIC: 2834 Pharmaceutical Preparations

Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900

Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824

Novo A/S (Filed by) CIK: 0001388325 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D